专利检索 ap:("Boehringer Ingelheim Vetmedica GmbH") AND inv:"Carla KROH" 第 1 页

1.

发明公开
USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF RENAL DISEASES IN NON-HUMAN MAMMALS 审中-公开

公开(公告)号：US20240307426A1

公开(公告)日：2024-09-19

申请号：US18578207

申请日：2022-07-26

申请人： BOEHRINGER INGELHEIM VETMEDICA GMBH

发明人： Carla KROH , Ingo Ulrich LANG , José MATALLO

IPC分类号： A61K31/7056 , A61K31/382 , A61K31/7034 , A61K31/7048 , A61P13/12

CPC分类号： A61K31/7056 , A61K31/382 , A61K31/7034 , A61K31/7048 , A61P13/12

摘要： The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of one or more renal diseases in a non-human mammal, such as a carnivore, in particular a cat or a dog.

2.

发明公开
USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES 审中-公开

公开(公告)号：US20240050456A1

公开(公告)日：2024-02-15

申请号：US18482334

申请日：2023-10-06

申请人： Boehringer Ingelheim Vetmedica GmbH

发明人： Carla KROH , Ingo Ulrich LANG , Horst ROSE , Franziska ROESSNER , Saskia KLEY

IPC分类号： A61K31/7034 , A61K47/54 , A61P9/04 , A61K31/138 , A61K31/341 , A61K31/401 , A61K31/4184 , A61K31/4422 , A61K31/501 , A61K31/554 , A61K31/585 , A61K31/616 , A61K31/7042 , A61K31/7048 , A61K31/7056 , A61K31/727

CPC分类号： A61K31/7034 , A61K47/545 , A61P9/04 , A61K31/138 , A61K31/341 , A61K31/401 , A61K31/4184 , A61K31/4422 , A61K31/501 , A61K31/554 , A61K31/585 , A61K31/616 , A61K31/7042 , A61K31/7048 , A61K31/7056 , A61K31/727

摘要： The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of one or more cardiac diseases in feline animals.

3.

发明公开
USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF HYPERTENSION IN NON-HUMAN MAMMALS 审中-公开

公开(公告)号：US20240269105A1

公开(公告)日：2024-08-15

申请号：US18578205

申请日：2022-07-26

申请人： BOEHRINGER INGELHEIM VETMEDICA GMBH

发明人： José MATALLO , Carla KROH , Christoph Matthias SCHUMMER

IPC分类号： A61K31/351 , A61K45/06 , A61P9/12

CPC分类号： A61K31/351 , A61K45/06 , A61P9/12

摘要： The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of hypertension in a non-human mammal, preferably a carnivore, in particular a cat or a dog.

4.

发明申请
USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES 有权

公开(公告)号：US20210260090A1

公开(公告)日：2021-08-26

申请号：US17176285

申请日：2021-02-16

申请人： Boehringer Ingelheim Vetmedica GmbH

发明人： Carla KROH , Ingo Ulrich LANG , Horst ROSE , Franziska ROESSNER , Saskia KLEY

IPC分类号： A61K31/7034 , A61K31/7042 , A61K31/7048 , A61K31/7056 , A61K47/54 , A61K31/616 , A61K31/727 , A61K31/4184 , A61K31/341 , A61K31/585 , A61K31/138 , A61K31/4422 , A61K31/554 , A61K31/401 , A61K31/501 , A61P9/04

摘要： The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of one or more cardiac diseases in feline animals